N/A N=50 Sinus Balloon Dilation in Pediatric Patients
Sinusitis
Primary: Technical Success: Sinuses Successfully Treated With Balloon Dilation — 157 sinus dilation attempts
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=30 Pharmacokinetics of Acetaminophen in Pediatric Patients With Congenital Heart Disease
Congenital Heart Disease
Primary: Acetaminophen Serum Concentrations — 19; 17; 13; 13 mcg/mL
N/A N=100 Point of Care Testing in Pediatric Patients Undergoing Major Surgery
Spinal Fusion · Cardiopulmonary Bypass
Primary: International Normalized Ratio (INR) on CoaguChek — 1.11; 4.6 ratio
N/A N=148 The Pediatric Intermed: A New Clinical Decision Making Tool
Inflammatory Bowel Disease
Primary: Pediatric INTERMED- Complexity Index — 24; 9.0; 4.0; 4.0 scores on a scale
N/A N=94 Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay
Post Operative Pain
Primary: Median Pain Score During Shift 1, as Measured With the Face, Legs, Activity, Cry, Consolability Scale — 1.0; 1.8; 1.5 units on a scale
N/A N=116 Pediatric Guideline Adherence and Outcomes- Argentina
TBI (Traumatic Brain Injury)
Primary: First 3-day Cumulative Intensive Care Unit (ICU) Traumatic Brain Injury (TBI) Guideline Adherence Rate, Overall — 81.7; 81.0; 83.7; 84.4 mean percentage of guideline…
Phase 2 N=16 Paediatric Safety Study in Cat-PAD
Rhinoconjunctivitis
Primary: Number of Subjects With AEs — 5; 12 participants
N/A N=41,054 Pediatric Blood Pressure Clinical Decision Support Tool (PedsBP CDS)
Hypertension
Primary: Blood Pressure Remeasurement — 245; 829; 1813 participants — p=<0.001
N/A N=28 T-DOC® 5 Fr Pediatric Clinical Investigation
Incontinence, Urge
Primary: The Number of Patients in Which the T-DOC® 5 Fr Catheters Are Safe in Measuring Urodynamic Pressures in Pediatric Subjects (12 Years of Age and Younger). — 28 Participants
N/A N=28 Pediatric Ease of Use ELLIPTA Items
Asthma
Primary: Number of Pediatric Participants With Problems Understanding Item Wording-Round 1 Interviews — 0; 0 Participants
N/A N=50 Pocket Echocardiography System (PES) for Detection of PDA in Neonates
Patent Ductus Arteriosus
Primary: False Positives Results of Pocket Echocardiography System (PES) Detection of Patent Ductus Arteriosus (PDA) to Full Featured Echo System (FFES) — 10.8 percentage of…
N/A N=134 Pediatric Catheter-related Thrombosis Imaging Study
Thrombosis
Primary: Total Number of Participants Who Completed the Study-Related Ultrasound (US) and Magnetic Resonance Imaging (MRI) With and Without Contrast — 133; 113; 113; 110…
Phase 2 N=30 Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)
Pediatric Cancer
Primary: Percentage of Pediatric Patients Age 3-7 Who Require Daily General Anesthesia for All Treatments — 88; 12 percentage of participants
N/A N=601 Gelatines in Pediatric PatientS
Treatment of Hypovolemia and Shock
Primary: Dosing of the Products During Surgery — 14.58; 12.64 ml/kg
Phase 4 N=34 Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy
Cerebral Palsy · Hip Dysplasia · Pain, Postoperative
Primary: Opioid Consumption — 0.41; 1.87 mEQ/kg
Phase 4 N=160 Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)
Supracondylar Humerus Fracture · Post Operative Wound Infection
Primary: Number of Participants With the Presence of Post-Operative Infection — 2; 2 Participants
Phase 4 N=6 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension · Hypertension, Pulmonary
Primary: Change From Baseline in Pulmonary Vascular Resistance Index (PVRI) at Week 16 — 18.567; -4.113 wood units*meter^2
N/A N=32 Artificial Pancreas in Pediatric Patients (PEDarPAN)
Type 1 Diabetes
Primary: Percentage of Time Spent With Blood Glucose < 3.9 mmol/L (or 70 mg/dl) — 2; 6.7 percentage
N/A N=200 Randomized Controlled Trial of a Patient Activation Tool in Pediatric Appendicitis (Antibiotics Alone vs. Appendectomy)
Appendicitis · Children
Primary: Decision Self-Efficacy Scale — 100; 100 units on a scale — p=0.03
Phase 4 N=96 Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients
Pediatrics · Anesthesia · Vasospasm
Primary: Number of Participants With Optimal Arterial Waveform — 27; 18 Participants
N/A N=100 PPV to Guide Fluid Management in the PICU
Sepsis · Systemic Inflammatory Response Syndrome
Primary: Total Fluid (ml/kg/Day) Given — 124.38; 122.099 ml/kg/day
N/A N=989 SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
Heart Defects, Congenital · Hyperglycemia
Primary: Incidence of Nosocomial Infections in the Cardiac ICU — 8.6; 9.9 infections / 1000 pt days
N/A N=142 Improving Informed Consent in Pediatric Endoscopy
Informed Consent · Procedural State Anxiety · Subject's Satisfaction
Primary: Attainment of Informed Consent as Measured by Consent Instrument (Consent-20) — 37.36; 33.2 Units on a scale — p=<0.0001
N/A N=22 Prevention of Post Operative Bone Loss in Children
Osteoporosis · Cerebral Palsy · Spina Bifida
Primary: Amount of Bone Density Lost (%) From pre-to Post-operative DXA Scan — 0.043; -0.025 percent change
Phase 4 N=5 Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Primary: Change in Systemic Vascular Resistance Index (SVRI) to Pulmonary Vascular Resistance Index (PVRI) Ratio (Rp:Rs Ratio) — 0.8; 0.75; 0.61; 0.73 Rp:Rs ratio — p=0.9
Phase 2 N=47 Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
Acute Leukaemia · Chronic Disease · Leukemia
Primary: Number of High Risk Pediatric Patients With Successful Sustained Donor Engraftments — 16; 18; 10 participants
N/A N=271 Impact of a Procalcitonin Testing and Treatment Algorithm on Antibiotic Use and Outcomes in the Pediatric Intensive Care Unit
Sepsis · Procalcitonin · Antimicrobial Stewardship
Primary: Days of Antibiotic Therapy in the First 14 Days Following Randomization — 7.6; 6.6 days
N/A N=64 SpO2 Data Collection in Pediatric Patients Using INVSENSOR00061
Spo2
Primary: SpO2 Accuracy of INVSENSOR00061 — 0.87 percent of oxygen saturated hemoglobin
Phase 4 N=41 Octaplas Pediatric Plasma Exchange Trial
Adverse Effects in the Therapeutic Use of Plasma Substitutes
Primary: Monitoring of Adverse Drug Reactions Caused by the Octaplas™Used for Plasma Exchange. — 0; 5; 3; 8 event
N/A N=482 The Use of Apneic Oxygenation During Prolonged Intubation in Pediatric Patients: a Randomized Clinical Trial
Intubation of Pediatric Dental Surgery Patients
Primary: Time of Oxygen Saturation Change — 30; 67; 75 seconds